share_log

Vaxart Analyst Ratings

Benzinga ·  Aug 7, 2023 21:02
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 419.68% Cantor Fitzgerald $6 → $4 Maintains Overweight
12/19/2022 94.88% B. Riley Securities $6 → $1.5 Maintains Neutral
09/02/2022 939.37% Cantor Fitzgerald $11 → $8 Maintains Overweight
05/19/2022 679.52% B. Riley Securities $7 → $6 Maintains Neutral
11/02/2021 1848.81% Cantor Fitzgerald → $15 Initiates Coverage On → Overweight
06/30/2021 1069.29% B. Riley Securities $13 → $9 Downgrades Buy → Neutral
06/24/2021 1588.97% Jefferies → $13 Initiates Coverage On → Buy
06/11/2021 2238.57% Piper Sandler → $18 Initiates Coverage On → Overweight
08/12/2020 2108.65% HC Wainwright & Co. $7 → $17 Maintains Buy
07/13/2020 2758.26% B. Riley Securities → $22 Initiates Coverage On → Buy
04/30/2020 809.45% HC Wainwright & Co. $3 → $7 Reiterates → Buy
06/27/2019 159.84% HC Wainwright & Co. → $2 Initiates Coverage On → Buy

What is the target price for Vaxart (VXRT)?

The latest price target for Vaxart (NASDAQ: VXRT) was reported by Cantor Fitzgerald on August 7, 2023. The analyst firm set a price target for $4.00 expecting VXRT to rise to within 12 months (a possible 419.68% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Vaxart (VXRT)?

The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by Cantor Fitzgerald, and Vaxart maintained their overweight rating.

When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

Is the Analyst Rating Vaxart (VXRT) correct?

While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a maintained with a price target of $6.00 to $4.00. The current price Vaxart (VXRT) is trading at is $0.77, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment